25.00
price down icon1.26%   -0.32
after-market  After Hours:  25.00 
loading
Surgery Partners Inc stock is currently priced at $25.00, with a 24-hour trading volume of 726.08K. It has seen a -1.26% decreased in the last 24 hours and a -7.27% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $25.69 pivot point. If it approaches the $24.68 support level, significant changes may occur.
Previous Close:
$25.32
Open:
$24.8
24h Volume:
726.08K
Market Cap:
$3.11B
Revenue:
$2.74B
Net Income/Loss:
$-11.90M
P/E Ratio:
-44.64
EPS:
-0.56
Net Cash Flow:
$205.00M
1W Performance:
-1.81%
1M Performance:
-7.27%
6M Performance:
-29.34%
1Y Performance:
-39.16%
1D Range:
Value
$24.27
$25.30
52W Range:
Value
$22.05
$45.79

Surgery Partners Inc Stock (SGRY) Company Profile

Name
Name
Surgery Partners Inc
Name
Phone
615-234-5900
Name
Address
310 Seven Springs Way, Suite 500, Brentwood, TN
Name
Employee
7,300
Name
Next Earnings Date
2024-06-06
Name
Latest SEC Filings
Name
SGRY's Discussions on Twitter

Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-14-23 Upgrade TD Cowen Market Perform → Outperform
Jun-02-23 Upgrade BofA Securities Neutral → Buy
May-12-23 Initiated Mizuho Buy
Apr-21-23 Initiated Cantor Fitzgerald Overweight
Nov-23-22 Reiterated RBC Capital Mkts Outperform
Jun-15-22 Downgrade BofA Securities Buy → Neutral
Jan-10-22 Resumed Citigroup Buy
Nov-30-21 Initiated Barclays Overweight
Nov-29-21 Upgrade Stifel Hold → Buy
Nov-01-21 Initiated JP Morgan Neutral
Oct-18-21 Initiated SVB Leerink Outperform
Sep-10-21 Initiated Cowen Market Perform
Jun-23-21 Resumed Stifel Hold
Sep-17-20 Reiterated The Benchmark Company Buy
Apr-27-20 Upgrade The Benchmark Company Hold → Buy
Mar-03-20 Downgrade The Benchmark Company Buy → Hold
Jan-14-20 Reiterated The Benchmark Company Buy
Nov-16-18 Initiated UBS Neutral
Sep-18-18 Upgrade BofA/Merrill Neutral → Buy
Jun-28-18 Upgrade Stifel Sell → Hold
Jan-30-18 Reiterated The Benchmark Company Buy
Nov-01-17 Downgrade BofA/Merrill Buy → Neutral
Aug-09-17 Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Aug-09-17 Downgrade Raymond James Strong Buy → Mkt Perform
Aug-09-17 Downgrade Stifel Hold → Sell
Apr-24-17 Reiterated Stifel Hold
Mar-10-17 Downgrade Stifel Buy → Hold
Jan-31-17 Initiated The Benchmark Company Buy
Jun-10-16 Initiated KeyBanc Capital Mkts Overweight
Mar-14-16 Reiterated RBC Capital Mkts Outperform
Oct-27-15 Initiated Stifel Buy
Oct-26-15 Initiated RBC Capital Mkts Outperform
Oct-26-15 Initiated Raymond James Strong Buy
View All

Surgery Partners Inc Stock (SGRY) Financials Data

Surgery Partners Inc (SGRY) Revenue 2024

SGRY reported a revenue (TTM) of $2.74 billion for the quarter ending December 31, 2023, a +8.03% rise year-over-year.
loading

Surgery Partners Inc (SGRY) Net Income 2024

SGRY net income (TTM) was -$11.90 million for the quarter ending December 31, 2023, a +78.21% increase year-over-year.
loading

Surgery Partners Inc (SGRY) Cash Flow 2024

SGRY recorded a free cash flow (TTM) of $205.00 million for the quarter ending December 31, 2023, a +162.15% increase year-over-year.
loading

Surgery Partners Inc (SGRY) Earnings per Share 2024

SGRY earnings per share (TTM) was -$0.10 for the quarter ending December 31, 2023, a +82.76% growth year-over-year.
loading

Surgery Partners Inc Stock (SGRY) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Owens Bradley R.
National Group President
May 31 '24
Sale
27.65
6,000
165,900
72,338
Doherty David T
Chief Financial Officer
Mar 14 '24
Sale
28.59
721
20,613
95,719
Evans Jason Eric
Chief Executive Officer
Mar 13 '24
Sale
29.71
4,840
143,796
459,670
Owens Bradley R.
National Group President
Mar 12 '24
Sale
29.82
2,783
82,989
78,338
Baldock Jennifer
Chief Admin & Dev Officer
Mar 12 '24
Sale
29.74
922
27,420
183,644
TAPARO ANTHONY
Chief Growth Officer
Mar 12 '24
Sale
29.87
787
23,508
102,321
Burkhalter Danielle
Chief Human Resources Officer
Mar 12 '24
Sale
29.74
111
3,301
36,354
Evans Jason Eric
Chief Executive Officer
Mar 11 '24
Sale
29.44
1,984
58,409
464,510
Baldock Jennifer
Chief Admin & Dev Officer
Mar 11 '24
Sale
29.70
675
20,048
184,566
TAPARO ANTHONY
Chief Growth Officer
Mar 11 '24
Sale
29.54
651
19,231
103,108
Surgery Partners, Inc., through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and a suite of ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of March 12, 2018, the company operated approximately 180 locations in 32 states, including ambulatory surgery centers, surgical hospitals, a diagnostic laboratory, multi-specialty physician practices, and urgent care facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
$27.87
price down icon 0.14%
$65.40
price down icon 1.42%
$118.96
price down icon 0.54%
medical_care_facilities CHE
$538.76
price up icon 0.06%
medical_care_facilities EHC
$84.30
price down icon 0.74%
medical_care_facilities FMS
$20.62
price down icon 0.82%
Cap:     |  Volume (24h):